Back to results
US 2011/0256107 A1Published application
Treatment of brain damage using umbilical cord blood cells
AssigneeStemCyte, Inc.
InventorsShinn-Zong Lin, Woei-Cherng Shyu, Hung Li
Life of this patent
Estimating the term…
Abstract
The invention relates to the treatment of chronic stroke, traumatic brain injury, and neurodegenerative disorders using umbilical cord blood cells.
Claims25
A method for treating chronic stroke comprising
- intraparenchymally administering, to a brain of a human subject who has experienced a stroke, an isolated umbilical cord blood cell population enriched in CD34+, CD133+, or CD34+/CD133+ cells, wherein the isolated umbilical cord blood cell population is administered more than 7 days after the stroke.
A method for treating brain tissue damage comprising
- intraparenchymally administering to a brain of a human subject who has experienced brain tissue damage an isolated umbilical cord blood cell population enriched in CD34+, CD133+, or CD34+/CD133+ umbilical cord blood cells.
24-45. (canceled)
A method for treating brain tissue damage comprising
- intraparenchymally administering to a brain of a human subject having brain tissue damage resulting from traumatic brain injury an isolated umbilical cord blood cell population enriched in CD34+, CD133+, or CD34+/CD133+ umbilical cord blood cells, wherein the cells are administered more than one month after the occurrence of the traumatic brain injury.
Dependencies are inferred from the claim text.